skip to main content
Idioma:
Resultados 1 2 3 next page
Refinado por: Base de dados/Biblioteca: HighWire Press (Free Journals) remover Nome da Publicação: Circulation remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)

Khera, Amit V ; Demler, Olga V ; Adelman, Steven J ; Collins, Heidi L ; Glynn, Robert J ; Ridker, Paul M ; Rader, Daniel J ; Mora, Samia

Circulation (New York, N.Y.), 2017-06, Vol.135 (25), p.2494-2504 [Periódico revisado por pares]

United States: by the American College of Cardiology Foundation and the American Heart Association, Inc

Texto completo disponível

Citações Citado por
2
Cholesterol Efflux Capacity, HDL Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
Cholesterol Efflux Capacity, HDL Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cholesterol Efflux Capacity, HDL Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)

Khera, Amit V. ; Demler, Olga V. ; Adelman, Steven J. ; Collins, Heidi L. ; Glynn, Robert J. ; Ridker, Paul M ; Rader, Daniel J. ; Mora, Samia

Circulation (New York, N.Y.), 2017-04, Vol.135 (25), p.2494-2504 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
3
Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension
Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension

BRÄHLER, Sebastian ; KAISTHA, Anuradha ; BOND, Chris T ; ADELMAN, John P ; WULFF, Heike ; DE WIT, Cor ; HOYER, Joachim ; KÖHLER, Ralf ; SCHMIDT, Volker J ; WÖLFLE, Stephanie E ; BUSCH, Christoph ; KAISTHA, Brajesh P ; KACIK, Michael ; HASENAU, Anna-Lena ; GRGIC, Ivica ; HAN SI

Circulation (New York, N.Y.), 2009-05, Vol.119 (17), p.2323-2332 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
4
Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle
Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle

GALLO, R ; PADUREAN, A ; BADIMON, J. J ; JAYARAMAN, T ; MARX, S ; ROQUE, M ; ADELMAN, S ; CHESEBRO, J ; FALLON, J ; FUSTER, V ; MARKS, A

Circulation (New York, N.Y.), 1999-04, Vol.99 (16), p.2164-2170 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
5
Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: Procedural and long-term results
Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: Procedural and long-term results
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: Procedural and long-term results

KEREIAKES, Dean J ; SZYNISZEWSKI, Arthur M ; CHOU, Tony M ; POPMA, Jeffrey ; FITZGERALD, Peter ; CARROLL, Tanya E ; FORER, David ; ADELMAN, Daniel C ; WAHR, Dennis ; HERRMANN, Howard C ; SIMON, Daniel I ; ROGERS, Campbell ; KRAMER, Paul ; SHEAR, Wendy ; YEUNG, Alan C ; SHUNK, Kendrick A

Circulation (New York, N.Y.), 2003-09, Vol.108 (11), p.1310-1315 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
6
Antiangiogenesis mediates cisplatin-induced peripheral neuropathy : Attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth
Antiangiogenesis mediates cisplatin-induced peripheral neuropathy : Attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antiangiogenesis mediates cisplatin-induced peripheral neuropathy : Attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth

KIRCHMAIR, Rudolf ; WALTER, Dirk H ; SCHRATZBERGER, Peter ; YOON, Young-Sup ; WEBER, Alberto ; PANAGIOTOU, Eleftheria ; ROSEN, Kenneth M ; BAHLMANN, Ferdinand H ; ADELMAN, Lester S ; WEINBERG, David H ; ROPPER, Allan H ; ISNER, Jeffrey M ; II, Masaaki ; LOSORDO, Douglas W ; RITTIG, Kilian ; TIETZ, Anne B ; MURAYAMA, Toshinori ; EMANUELI, Costanza ; SILVER, Marcy ; WECKER, Andrea ; AMANT, Carole

Circulation (New York, N.Y.), 2005-05, Vol.111 (20), p.2662-2670 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
7
Randomized, double-blind comparison of Hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO)
Randomized, double-blind comparison of Hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized, double-blind comparison of Hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO)

WHITE, H. D ; AYLWARD, P. E ; MARAGANORE, J ; ADELMAN, B ; FREY, M. J ; ADGEY, A. A. J ; NAIR, R ; HILLIS, W. S ; SHALEV, Y ; BROWN, M. A ; FRENCH, J. K ; COLLINS, R

Circulation (New York, N.Y.), 1997-10, Vol.96 (7), p.2155-2161 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
8
Photoangioplasty for human peripheral atherosclerosis: Results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin)
Photoangioplasty for human peripheral atherosclerosis: Results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Photoangioplasty for human peripheral atherosclerosis: Results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin)

ROCKSON, Stanley G ; KRAMER, Paul ; ADELMAN, Daniel C ; RAZAVI, Mahmood ; SZUBA, Andrzej ; FILARDO, Steven ; FITZGERALD, Peter ; COOKE, John P ; YOUSUF, Shuja ; DEVAULT, Arthur R ; RENSCHLER, Markus F

Circulation (New York, N.Y.), 2000-11, Vol.102 (19), p.2322-2324 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
9
Abstract 19972: Use of Whole Exome Sequencing for the Identification of Ito Based Arrhythmia Mechanism and Therapy
Abstract 19972: Use of Whole Exome Sequencing for the Identification of Ito Based Arrhythmia Mechanism and Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract 19972: Use of Whole Exome Sequencing for the Identification of Ito Based Arrhythmia Mechanism and Therapy

Adelman, Sara H ; Sturm, Amy C ; Kline, Crystal F ; Glynn, Patric ; Johnson, Benjamin L ; Curran, Jerry ; Kilic, Ahmet ; Higgins, Robert S ; Binkley, Philip F ; Janssen, Paul M ; Weiss, Raul ; Raman, Subha V ; Fowler, Steven J ; Priori, Silvia G ; Hund, Thomas J ; Carnes, Cynthia A ; Mohler, Peter J

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A19972-A19972 [Periódico revisado por pares]

by the American College of Cardiology Foundation and the American Heart Association, Inc

Texto completo disponível

Citações Citado por
10
A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions
A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions
Material Type:
Artigo 		Adicionar ao Meu Espaço

A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions

HOLMES, D. R ; TOPOL, E. J ; TALLEY, J. D ; SHANI, J ; GOTTLIEB, R. S ; PINKERTON, C. A ; LEE, K. L ; KEELER, G. P ; ELLIS, S. G ; CALIFF, R. M ; BERDAN, L. G ; LEYA, F ; BERGER, P. B ; WHITLOW, P. L ; SAFIAN, R. D ; ADELMAN, A. G ; KELLETT, M. A

Circulation (New York, N.Y.), 1995-04, Vol.91 (7), p.1966-1974 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.